written on 29.05.2014

With new hopes for German pricing, Novo Nordisk decides to roll out Tresiba there


Novo Nordisk has decided to play ball in Germany. The Danish drugmaker now plans to launch its brand-new diabetes drug Tresiba in that country, despite a notorious pricing policy that Novo feared would interfere with its success.